A detailed history of Noesis Capital Mangement Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 2,115 shares of ABT stock, worth $243,796. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,115
Holding current value
$243,796
% of portfolio
0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $211,648 - $249,844
2,115 New
2,115 $241 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $38,511 - $47,140
-427 Reduced 18.9%
1,832 $202 Million
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $76,424 - $91,696
-800 Reduced 26.15%
2,259 $219 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $43,738 - $48,733
-434 Reduced 12.42%
3,059 $333 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $20,824 - $24,512
-215 Reduced 5.8%
3,493 $354 Million
Q4 2022

Feb 02, 2023

BUY
$95.06 - $111.52 $10,171 - $11,932
107 Added 2.97%
3,708 $407 Million
Q3 2022

Nov 01, 2022

BUY
$96.76 - $112.03 $1,548 - $1,792
16 Added 0.45%
3,601 $348 Million
Q2 2022

Jul 29, 2022

BUY
$102.07 - $123.37 $109,214 - $132,005
1,070 Added 42.54%
3,585 $389,000
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $83,462 - $101,777
-732 Reduced 22.54%
2,515 $297,000
Q4 2021

Feb 03, 2022

SELL
$115.53 - $141.46 $1,617 - $1,980
-14 Reduced 0.43%
3,247 $456,000
Q3 2021

Nov 04, 2021

BUY
$116.66 - $129.06 $121,559 - $134,480
1,042 Added 46.96%
3,261 $385,000
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $13,223 - $15,566
-125 Reduced 5.33%
2,219 $257,000
Q1 2021

May 06, 2021

SELL
$108.84 - $128.23 $20,788 - $24,491
-191 Reduced 7.53%
2,344 $280,000
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $13,125 - $14,302
-125 Reduced 4.7%
2,535 $277,000
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $91,640 - $111,290
-1,000 Reduced 27.32%
2,660 $289,000
Q1 2020

May 06, 2020

SELL
$62.82 - $91.86 $3,015 - $4,409
-48 Reduced 1.29%
3,660 $288,000
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $19,391 - $21,587
-247 Reduced 6.25%
3,708 $322,000
Q2 2019

Aug 06, 2019

SELL
$72.88 - $85.0 $2,040 - $2,380
-28 Reduced 0.7%
3,955 $0
Q1 2019

May 09, 2019

SELL
$66.22 - $80.06 $12,581 - $15,211
-190 Reduced 4.55%
3,983 $0
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $51,857 - $58,747
791 Added 23.39%
4,173 $302,000
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $9,121 - $11,004
-150 Reduced 4.25%
3,382 $248,000
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $3,684 - $4,066
-64 Reduced 1.78%
3,532 $215,000
Q1 2018

May 07, 2018

BUY
$56.27 - $63.62 $112 - $127
2 Added 0.06%
3,596 $215,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $16,104 - $17,241
-300 Reduced 7.7%
3,594 $205,000
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $187,145 - $208,874
3,894
3,894 $208,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Noesis Capital Mangement Corp Portfolio

Follow Noesis Capital Mangement Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

News

Stay updated on Noesis Capital Mangement Corp with notifications on news.